Monrovia, CA, January 26, 2008 --(PR.com
)-- GTCbio is announcing the 4th international Stem Cell Research & Therapeutics Conference taking place on April 17-18, 2008 in Boston, MA. The conference covers the latest developments in all aspects of stem cell research from leading stem cell companies, universities and government organizations.
The goal of the Conference is to provide an overview of the state of art in the field of stem cells, bringing together a mix of academic, industry (Pharma and Biotech) and public sector experts in an intimate setting that favors the showcase of data, the exchange of ideas and networking.
Attendees learn from top leaders and experts on adult stem cells, embryonic stem cells, differentiation, epigenomics & reprogramming, regenerative medicine & therapeutics, stem cell imaging, cancer stem cells, stem cell applications in drug discovery, and stem cells regulatory aspects & funding opportunities.
The keynote speaker, Dr. Rudolf Jaenisch who is a founding Member of the Whitehead Institute and a pioneer of transgenic science will open the conference with a talk on his latest research. Dr. Jaenisch is a leader in the field of therapeutic cloning, also called nuclear transfer. The conference also features presentations from leading organizations such as Beckman Research Institute, FDA, Genzyme, Merck, MIT, Pfizer, Sangamo BioSciences, Sanofi Aventis, University of Van Amsterdam, and many more. The full agenda is available online at www.gtcbio.com.
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, email@example.com